Funding for the expansion of the Valneva factory in Livingston, Scotland.<\/li><\/ul>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-23T13:42:47.927Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2021-04-15", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Vaccination: Manufacturing Industries"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Business, Energy and Industrial Strategy, what steps the Department is taking to support British domestic capacity to produce future vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4490", "label" : {"_value" : "Biography information for Dame Andrea Jenkyns"}
}
, "tablingMemberConstituency" : {"_value" : "Morley and Outwood"}
, "tablingMemberPrinted" : [{"_value" : "Andrea Jenkyns"}
], "uin" : "181349"}
, {"_about" : "http://data.parliament.uk/resources/1308939", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1308939/answer", "answerText" : {"_value" : "There are no plans to do so.<\/p>
On 13 April, the Joint Committee on Vaccination and Immunisation (JCVI) published their final advice on phase two of the COVID-19 vaccination programme, which was to continue with an age-based programme. Students planning to study abroad in the 2021-22 academic year will receive their vaccinations in line with that advice when they become eligible because of their age, individual clinical risk factors, or because they are students who work as frontline health or social care workers or are unpaid carers. In line with other adults in the United Kingdom, they can expect to receive their first dose by the end of July 2021 and their second dose within 12 weeks of their first.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-23", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-23T08:45:32.217Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-04-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "British Students Abroad: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an announcement on the covid-19 vaccine priority applicable to students planning to study abroad in the 2021-22 academic year; and if he will make it his policy that those students will be eligible to receive both doses of that vaccine prior to the start of that academic year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4462", "label" : {"_value" : "Biography information for Tom Tugendhat"}
}
, "tablingMemberConstituency" : {"_value" : "Tonbridge and Malling"}
, "tablingMemberPrinted" : [{"_value" : "Tom Tugendhat"}
], "uin" : "181058"}
, {"_about" : "http://data.parliament.uk/resources/1308990", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1308990/answer", "answerText" : {"_value" : "
The National Health Service has written to all general practitioner practices setting out how vaccines will be offered to this group and how eligible individuals are to be identified. A separate \u2018Operational Guide\u2019 has been created setting out more details and how the NHS plans to maximise uptake in this group. The NHS has also written to all Medical Directors setting out the steps needed to identify immunosuppressed individuals in secondary care.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1308990/answer/previousversion/97235", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
}
, "questionFirstAnswered" : [{"_value" : "2021-04-22T09:17:06.027Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-04-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that all GPs are aware of the update to JCVI guidance on prioritisation of adults for the covid-19 living with immunocompromised clinically extremely vulnerable people.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4641", "label" : {"_value" : "Biography information for Alex Norris"}
}
, "tablingMemberConstituency" : {"_value" : "Nottingham North"}
, "tablingMemberPrinted" : [{"_value" : "Alex Norris"}
], "uin" : "181092"}
, {"_about" : "http://data.parliament.uk/resources/1308991", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1308991/answer", "answerText" : {"_value" : "
We do not yet have a specific timeline for publishing this data. Information on the vaccination programme is regularly reviewed and new datasets are added as available.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-22", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1308991/answer/previousversion/97251", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
}
, "questionFirstAnswered" : [{"_value" : "2021-04-22T09:19:27.937Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-04-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, when his Department plans to publish data on the roll-out of the covid-19 vaccine to adult household members of immunocompromised clinically extremely vulnerable groups.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4641", "label" : {"_value" : "Biography information for Alex Norris"}
}
, "tablingMemberConstituency" : {"_value" : "Nottingham North"}
, "tablingMemberPrinted" : [{"_value" : "Alex Norris"}
], "uin" : "181093"}
, {"_about" : "http://data.parliament.uk/resources/1308454", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1308454/answer", "answerText" : {"_value" : "
All currently deployed COVID-19 vaccines in the United Kingdom are effective against the prevalent strains in the country.<\/p>
Public Health England has published early estimates of vaccine effectiveness which includes the United Kingdom variant of concern VOC202012/01 and has shown no substantial change in vaccine effectiveness against this variant, which is now the dominant strain of COVID-19 in the UK. If other emerging variants do reduce vaccine efficacy, it would still be anticipated that the vaccines currently in deployment would continue to provide protection to some extent.<\/p>
The Government are already taking several steps to understand the efficacy of the current UK vaccine portfolio against new and emerging virus variants. This includes a partnership with CureVac to develop a variation of an existing vaccine tailored to the most appropriate variant target.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-20T15:31:12.037Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-04-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether certain variants of covid-19 are less susceptible to vaccines.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "180499"}
, {"_about" : "http://data.parliament.uk/resources/1308569", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1308569/answer", "answerText" : {"_value" : "
There is currently no trial data available on the immune responses to mixed COVID-19 vaccine schedules. Such data are being developed by the National Immunisation Schedule Evaluation Consortium and will be considered by the Joint Committee on Vaccination and Immunisation (JCVI) when available. The JCVI advises that all those who have received a first dose of the Oxford/AstraZeneca COVID-19 vaccine should continue to be offered a second dose of that vaccine, irrespective of age. The second dose will be important for longer lasting protection against COVID-19. The JCVI\u2019s statement on the use of the Oxford/AstraZeneca vaccine is available at the following link:<\/p>
https://www.gov.uk/government/publications/use-of-the-astrazeneca-covid-19-vaccine-jcvi-statement/jcvi-statement-on-use-of-the-astrazeneca-covid-19-vaccine-7-april-2021<\/a><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1308569/answer/previousversion/97263", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
}
, "questionFirstAnswered" : [{"_value" : "2021-04-21T10:05:30.067Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-04-13", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of using a different covid-19 vaccine to Oxford-AstraZeneca for under 30 year olds who have already had their first dose of that vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4776", "label" : {"_value" : "Biography information for Munira Wilson"}
}
, "tablingMemberConstituency" : {"_value" : "Twickenham"}
, "tablingMemberPrinted" : [{"_value" : "Munira Wilson"}
], "uin" : "180615"}
, {"_about" : "http://data.parliament.uk/resources/1306931", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1306931/answer", "answerText" : {"_value" : "Phase two of the vaccination programme will cover all adults under 50 years old not already included in phase one. The Joint Committee on Vaccination and Immunisation (JCVI) has concluded that the most effective way to minimise hospitalisations and deaths is to continue to prioritise people by age, as this is assessed to be the strongest factor linked to mortality, morbidity and hospitalisations and because the speed of delivery is crucial to provide more people with protection from COVID-19. Seafarers and aircrew, in line with the JCVI\u2019s advice, will therefore be prioritised for vaccination according to their age and clinical risk along with the rest of the population. They will not be prioritised based on their occupation.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"}
}
, "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"}
, "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"}
, "dateOfAnswer" : {"_value" : "2021-04-19", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-04-19T09:06:30.3Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-04-12", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his policies on the prioritisation of covid-19 vaccines of the Joint Statement on prioritisation of COVID-19 vaccination for seafarers and aircrew by the International Civil Aviation Organization, International Labour Organization, International Maritime Organization, International Organization for Migration and World Health Organization, published on 25 March 2021, that calls on Governments to prioritise seafarers and aircrew in their national covid-19 vaccination programmes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4866", "label" : {"_value" : "Biography information for Alexander Stafford"}
}
, "tablingMemberConstituency" : {"_value" : "Rother Valley"}
, "tablingMemberPrinted" : [{"_value" : "Alexander Stafford"}
], "uin" : "178583"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=1&answer.answeringMemberPrinted=Nadhim+Zahawi&max-answer.questionFirstAnswered.=2021-04-23T13%3A45%3A10.293Z", "page" : 0, "startIndex" : 1, "totalResults" : 3924, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}